These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 22970361)

  • 21. Matrix metalloproteinase inhibitors.
    Wojtowicz-Praga SM; Dickson RB; Hawkins MJ
    Invest New Drugs; 1997; 15(1):61-75. PubMed ID: 9195290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Matrix metalloproteinases: their biological functions and clinical implications.
    Hijova E
    Bratisl Lek Listy; 2005; 106(3):127-32. PubMed ID: 16026148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Series "matrix metalloproteinases in lung health and disease": Biological role of matrix metalloproteinases: a critical balance.
    Löffek S; Schilling O; Franzke CW
    Eur Respir J; 2011 Jul; 38(1):191-208. PubMed ID: 21177845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic implications of the specific inhibition of causative matrix metalloproteinases in experimental colitis induced by dextran sulphate sodium.
    Kobayashi K; Arimura Y; Goto A; Okahara S; Endo T; Shinomura Y; Imai K
    J Pathol; 2006 Jul; 209(3):376-83. PubMed ID: 16552705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of the matrix metalloproteinases during in vitro vessel formation.
    Burbridge MF; Cogé F; Galizzi JP; Boutin JA; West DC; Tucker GC
    Angiogenesis; 2002; 5(3):215-26. PubMed ID: 12831062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sub-Cellular Localization of Metalloproteinases in Megakaryocytes.
    Malara A; Ligi D; Di Buduo CA; Mannello F; Balduini A
    Cells; 2018 Jul; 7(7):. PubMed ID: 30037039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Matrix metalloproteinases in skeletal muscles: friends or foes?
    Alameddine HS
    Neurobiol Dis; 2012 Dec; 48(3):508-18. PubMed ID: 22885251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MMPs: a novel drug target for schizophrenia.
    Chopra K; Baveja A; Kuhad A
    Expert Opin Ther Targets; 2015 Jan; 19(1):77-85. PubMed ID: 25214056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Matrix metalloproteinases and their inhibitors in Fuchs endothelial corneal dystrophy.
    Xu I; Thériault M; Brunette I; Rochette PJ; Proulx S
    Exp Eye Res; 2021 Apr; 205():108500. PubMed ID: 33617849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spatial and temporal analysis of nociception-related spinal cord matrix metalloproteinase expression in a murine neuropathic pain model.
    Liou JT; Sum DC; Liu FC; Mao CC; Lai YS; Day YJ
    J Chin Med Assoc; 2013 Apr; 76(4):201-10. PubMed ID: 23557887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Matrix Metalloproteinases (MMPs) in Targeted Drug Delivery: Synthesis of a Potent and Highly Selective Inhibitor against Matrix Metalloproteinase- 7.
    Wang LL; Zhang B; Zheng MH; Xie YZ; Wang CJ; Jin JY
    Curr Top Med Chem; 2020; 20(27):2459-2471. PubMed ID: 32703131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Matrix metalloproteinases: what do they not do? New substrates and biological roles identified by murine models and proteomics.
    Rodríguez D; Morrison CJ; Overall CM
    Biochim Biophys Acta; 2010 Jan; 1803(1):39-54. PubMed ID: 19800373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiphasic roles for matrix metalloproteinases after stroke.
    Rosell A; Lo EH
    Curr Opin Pharmacol; 2008 Feb; 8(1):82-9. PubMed ID: 18226583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Matrix metalloproteinase 2 and membrane type 1 matrix metalloproteinase co-regulate axonal outgrowth of mouse retinal ganglion cells.
    Gaublomme D; Buyens T; De Groef L; Stakenborg M; Janssens E; Ingvarsen S; Porse A; Behrendt N; Moons L
    J Neurochem; 2014 Jun; 129(6):966-79. PubMed ID: 24611815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Matrix metalloproteinases in neural development: a phylogenetically diverse perspective.
    Small CD; Crawford BD
    Neural Regen Res; 2016 Mar; 11(3):357-62. PubMed ID: 27127457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural basis of the matrix metalloproteinases and their physiological inhibitors, the tissue inhibitors of metalloproteinases.
    Bode W; Maskos K
    Biol Chem; 2003 Jun; 384(6):863-72. PubMed ID: 12887053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Matrix metalloproteinases in the progression of heart failure: potential therapeutic implications.
    Li YY; Feldman AM
    Drugs; 2001; 61(9):1239-52. PubMed ID: 11511020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Matrix metalloproteinases in squamous cell carcinoma.
    Johansson N; Kähäri VM
    Histol Histopathol; 2000 Jan; 15(1):225-37. PubMed ID: 10668212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Matrix metalloproteinases in the normal human central nervous system, microglial nodules, and multiple sclerosis lesions.
    Maeda A; Sobel RA
    J Neuropathol Exp Neurol; 1996 Mar; 55(3):300-9. PubMed ID: 8786388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Matrix metalloproteinases: multifunctional effectors of inflammation in multiple sclerosis and bacterial meningitis.
    Leppert D; Lindberg RL; Kappos L; Leib SL
    Brain Res Brain Res Rev; 2001 Oct; 36(2-3):249-57. PubMed ID: 11690622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.